广东嘉应制药股份有限公司 关于公司2024年员工持股计划完成 开户的公告

Group 1 - The company has completed the establishment of a securities account for its 2024 employee stock ownership plan, with the account opened on October 23, 2025 [1][2] - The company currently does not hold any stocks under the 2024 employee stock ownership plan and will continue to monitor its implementation progress [2] - The company has disclosed the relevant documents regarding the securities account opening [3] Group 2 - The company's wholly-owned subsidiary, Jiying Pharmaceutical (Hunan) Co., Ltd., has changed its business scope and completed the industrial and commercial registration [4][5] - The new business scope includes drug production, drug wholesale and retail, food production and sales, and other related activities [5] - The subsidiary has obtained a new business license reflecting these changes [6]